Comparable stake leader
FMR LLC
Top holders, 13D/G large-stake signals, insider positions, and transaction flow tied to CIK 0001604821.
Comparable stake leader
FMR LLC
Disclosed value leader
FMR LLC
Comparable rows
5/50
Latest evidence
02 Nov 2026
Ownership snapshot
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Quick read
5 of 50 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| FMR LLC |
13D/G
|
10%
Reported 13D/G
· 30 Oct 2026
|
$5,986,828,286
15,131,245 shares
|
+$582,307,066 | 30 Oct 2026 |
| JPMORGAN CHASE & CO |
13D/G
|
9.1%
Reported 13D/G
· 31 Dec 2025
|
$2,938,225,868
12,825,640 shares
|
+$511,187,761 | 31 Dec 2025 |
| BlackRock, Inc. |
13D/G
|
5.6%
Reported 13D/G
· 31 Mar 2025
|
$1,157,512,549
7,565,936 shares
|
$0 | 31 Mar 2025 |
| VANGUARD CAPITAL MANAGEMENT LLC |
13F
13D/G
Company · Vanguard Capital Management
|
5.1%
Reported 13D/G
· 31 Mar 2026
|
$2,578,802,281
6,239,390 shares
|
— | 30 Sep 2026 |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13D/G
T. Rowe Price Associates, Inc.
|
4.7%
Reported 13D/G
· 30 Sep 2026
|
$2,684,955,486
6,786,017 shares
|
-$884,619,793 | 30 Sep 2026 |
| VANGUARD PORTFOLIO MANAGEMENT LLC |
13F
Company
|
—
denominator unverified
|
$2,370,100,156
5,734,437 shares
|
— | 30 Sep 2026 |
| STATE STREET CORP |
13F
Company
|
—
denominator unverified
|
$1,523,349,066
3,685,730 shares
|
— | 30 Sep 2026 |
| Duquesne Family Office LLC |
13F
Company
|
—
denominator unverified
|
$1,306,335,000
3,160,666 shares
|
— | 30 Sep 2026 |
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Forms 3/4/5 flow
Net insider flow leans to selling over the last 12 months. Net value: -$365,591,600.
| Window (months) | Buy shares | Sell shares | Buy value | Sell value | Net value |
|---|---|---|---|---|---|
| 0-3 | 0 | 290,819 | $0 | $104,832,418 | -$104,832,418 |
| 3-6 | 0 | 370,805 | $0 | $87,316,169 | -$87,316,169 |
| 6-9 | 0 | 284,276 | $0 | $55,361,582 | -$55,361,582 |
| 9-12 | 0 | 505,922 | $0 | $118,081,432 | -$118,081,432 |
Reporting owners
Showing 1-19 of 19 reporting-owner rows connected to Natera, Inc.. Open a relationship link for the CIK-to-CIK filing trail.
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Valuation | Report Date |
|---|---|---|---|---|---|---|
| Matthew Rabinowitz | EXECUTIVE CHAIRMAN, Director | $847,394,000 | -$135,262,412 | -14% | Filing P/S | 02 Nov 2026 |
| James Healy | Director | $225,766,720 | Mixed | 25 Apr 2025 | ||
| Roelof Botha | Director | $216,145,792 | -$34,893,028 | -14% | Mixed | 26 Jun 2026 |
| Jonathan Sheena | Director, CO-FOUNDER | $93,497,976 | -$30,834,043 | -25% | Mixed | 11 Nov 2026 |
| John Fesko | President, Chief Bus. Officer | $78,167,850 | -$9,774,793 | -11% | Filing P/S | 02 Nov 2026 |
| Daniel Rabinowitz | Sec. And Chief Legal Officer | $67,568,332 | -$24,047,489 | -26% | Mixed | 02 Nov 2026 |
| Solomon Moshkevich | President, Clinicaldiagnostics | $42,195,537 | -$24,873,006 | -37% | Filing P/S | 02 Nov 2026 |
| Steven Leonard Chapman | CEO AND PRESIDENT, Director | $38,934,584 | -$61,106,635 | -61% | Mixed | 02 Nov 2026 |
| Michael Burkes Brophy | Chief Financial Officer | $18,811,268 | -$22,692,827 | -55% | Mixed | 02 Nov 2026 |
| Robert Alan Schueren | Chief Operating Officer | $9,082,035 | Mixed | 27 Jan 2023 | ||
| Roy D. Baynes | Director | $4,031,398 | -$1,710,600 | -30% | Mixed | 26 Jun 2026 |
| Gail Boxer Marcus | Director | $1,778,045 | -$2,389,328 | -57% | Mixed | 26 Jun 2026 |
| Monica Bertagnolli | Director | $1,403,929 | Mixed | 26 Jun 2026 | ||
| Rowan E. Chapman | Director | $1,281,485 | -$1,764,374 | -58% | Filing P/S | 15 Jul 2026 |
| Herm Rosenman | Director | $1,185,340 | -$15,143,977 | -93% | Mixed | 26 Jun 2026 |
| Brinkley Ruth Williams | Director | $1,094,945 | Mixed | 24 Apr 2026 | ||
| Todd C. Cozzens | Director | $1,038,936 | Mixed | 25 May 2022 | ||
| Eric H. Rubin | Director | $440,777 | Mixed | 26 Jun 2026 | ||
| Thomas J. Lynch Jr. | Director | $380,980 | Mixed | 26 Jun 2026 |
Showing up to 300 recent insider transactions from the last 12 months.
| Insider | Symbol | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares owned | Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|---|
| Jonathan Sheena | NTRA | Common Stock | Sale | -9.09% | -$239,553 | $319.40 | -750 | 7,500 | 11 Nov 2026 | By Caraluna 2 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -8.65% | -$226,782 | $319.41 | -710 | 7,500 | 11 Nov 2026 | By Caraluna 1 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.48% | -$12,610 | $315.26 | -40 | 8,210 | 11 Nov 2026 | by Caraluna 1 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.45% | -$995,405 | $316.00 | -3,150 | 214,462 | 06 Nov 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -1.02% | -$184,000 | $391.49 | -470 | 45,779 | 03 Nov 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.05% | -$44,797 | $399.97 | -112 | 217,574 | 02 Nov 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -0.04% | -$299,214 | $400.02 | -748 | 2,116,928 | 02 Nov 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.2% | -$136,416 | $400.05 | -341 | 167,880 | 02 Nov 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -3.26% | -$1,400,994 | $409.77 | -3,419 | 101,323 | 02 Nov 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.15% | -$120,804 | $400.01 | -302 | 195,276 | 02 Nov 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -4.17% | -$1,565,239 | $411.80 | -3,801 | 87,431 | 02 Nov 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -0.7% | -$129,998 | $399.99 | -325 | 46,249 | 02 Nov 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -3.93% | -$811,098 | $425.55 | -1,906 | 46,574 | 30 Oct 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -2.37% | -$502,372 | $426.46 | -1,178 | 48,480 | 28 Oct 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.09% | -$79,726 | $426.34 | -187 | 217,686 | 28 Oct 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.57% | -$412,698 | $426.34 | -968 | 168,221 | 28 Oct 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -1.1% | -$495,408 | $426.34 | -1,162 | 104,742 | 28 Oct 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.46% | -$382,854 | $426.34 | -898 | 195,578 | 28 Oct 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -3.62% | -$1,462,348 | $426.34 | -3,430 | 91,232 | 28 Oct 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -2.36% | -$510,756 | $426.34 | -1,198 | 49,658 | 28 Oct 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -0.13% | -$118,146 | $406.00 | -291 | 217,873 | 27 Oct 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -0.08% | -$697,508 | $406.00 | -1,718 | 2,117,676 | 27 Oct 2026 | Direct |
| Daniel Rabinowitz | NTRA | Common Stock | Sale | -0.52% | -$358,904 | $406.00 | -884 | 169,189 | 27 Oct 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -0.94% | -$410,060 | $406.00 | -1,010 | 105,904 | 27 Oct 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -0.4% | -$317,086 | $406.00 | -781 | 196,476 | 27 Oct 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -2.34% | -$919,184 | $406.00 | -2,264 | 94,662 | 27 Oct 2026 | Direct |
| Michael Burkes Brophy | NTRA | Common Stock | Sale | -1.51% | -$317,086 | $406.00 | -781 | 50,856 | 27 Oct 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.42% | -$1,293,246 | $410.55 | -3,150 | 218,164 | 21 Oct 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -8.33% | -$301,871 | $402.49 | -750 | 8,250 | 16 Oct 2026 | By Caraluna 2 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -3% | -$103,621 | $406.36 | -255 | 8,250 | 16 Oct 2026 | by Caraluna 1 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -5.5% | -$198,219 | $400.44 | -495 | 8,505 | 16 Oct 2026 | By Caraluna 1 Trust |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.3% | -$20,132,028 | $402.64 | -50,000 | 2,119,394 | 15 Oct 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Options Exercise | 2.36% | 50,000 | 2,169,394 | 15 Oct 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Stock Option (right to buy) | Options Exercise | -100% | -50,000 | 0 | 15 Oct 2026 | Direct | ||
| Matthew Rabinowitz | NTRA | Common Stock | Gift | -0.28% | -6,000 | 2,119,394 | 07 Oct 2026 | Direct | ||
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -1.3% | -$526,144 | $413.31 | -1,273 | 96,926 | 01 Oct 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -2.73% | -$1,242,645 | $414.22 | -3,000 | 106,914 | 01 Oct 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -50.1% | -$3,504,367 | $387.99 | -9,032 | 9,000 | 23 Sep 2026 | By Caraluna 2 Trust |
| Jonathan Sheena | NTRA | Common Stock | Sale | -50.1% | -$3,504,606 | $388.02 | -9,032 | 9,000 | 23 Sep 2026 | By Caraluna 1 Trust |
| Solomon Moshkevich | NTRA | Common Stock | Gift | -0.85% | -945 | 109,914 | 16 Sep 2026 | Direct | ||
| Jonathan Sheena | NTRA | Common Stock | Sale | -1.4% | -$1,115,714 | $354.19 | -3,150 | 221,314 | 16 Sep 2026 | Direct |
| Jonathan Sheena | NTRA | Common Stock | Sale | -2.6% | -$2,100,431 | $350.07 | -6,000 | 224,464 | 15 Sep 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -100% | -$700,014 | $350.01 | -2,000 | 0 | 15 Sep 2026 | By spouse |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.3% | -$17,359,280 | $347.19 | -50,000 | 2,125,394 | 15 Sep 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.25% | -$16,737,977 | $334.76 | -50,000 | 2,175,394 | 14 Sep 2026 | Direct |
| Matthew Rabinowitz | NTRA | Common Stock | Sale | -2.2% | -$16,398,267 | $327.97 | -50,000 | 2,225,394 | 11 Sep 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -12% | -$4,955,713 | $326.89 | -15,160 | 110,859 | 02 Sep 2026 | Direct |
| Solomon Moshkevich | NTRA | Common Stock | Sale | -2.33% | -$962,194 | $320.73 | -3,000 | 126,019 | 01 Sep 2026 | Direct |
| Steven Leonard Chapman | NTRA | Common Stock | Sale | -1.7% | -$545,041 | $320.99 | -1,698 | 98,199 | 01 Sep 2026 | Direct |
| John Fesko | NTRA | Common Stock | Sale | -3.2% | -$2,095,411 | $321.53 | -6,517 | 197,257 | 10 Aug 2026 | Direct |